| Metric | Value (₹ Cr) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 37.75 | 17.6% | 13.9% |
| Total Income | 38.19 | 16.9% | 13.1% |
| Expenditure | 47.28 | 11.9% | 8.8% |
| PBT | -9.08 | 18.1% | 1909.6% |
| Net Profit | -7.12 | 1.8% | 6814.3% |
| OPM | -6.16% | 4.23pp | 1.78pp |
| NPM | -18.63% | 3.42pp | 18.87pp |
| EPS | 6.88 | 1.8% | 6780.0% |
Natural Capsules Q3 & 9MFY26 Results: Revenue Up, EBITDA Margins Down
13 Feb 2026 · 13 Feb, 11:22 pm
Summary
Natural Capsules Limited, a leading manufacturer of hard capsules shell, has announced its financial results for the quarter ended December 31, 2025. The company's revenue increased to 37.75 Cr, but EBITDA margins decreased to 6.16%. The US trade tariffs impacting the company's HPMC capsules have been eased, restoring visibility on growth in the US market. The company is working on a structured path forward for its fermentation block and expects a meaningful improvement in the current quarter.
Key Highlights
- 1
Revenue for Q3 FY26 is 37.75 Cr (vs 35.42 Cr in Q2 FY26 and 35.42 Cr in Q3 FY25)
- 2
EBITDA margins for Q3 FY26 are at 6.16% (vs 8.16% in Q2 FY26 and 14.36% in Q3 FY25)
- 3
PAT for Q3 FY26 is 7.12 Cr (vs 7.35 Cr in Q2 FY26 and 11.58 Cr in Q3 FY25)
- 4
Revenue for 9M FY26 is 128.75 Cr (vs 125.86 Cr in 9M FY25)
- 5
PAT for 9M FY26 is 19.69 Cr (vs 19.78 Cr in 9M FY25)
- 6
US trade tariffs on HPMC capsules have been eased
Management Comments
Mr. Sunil Mundra
Executive Director
In Q3FY26, the capsules business operations were impacted by the temporary shutdown of the Puducherry unit following the regulatory action relating to the manufacturing licence... With these developments, we enter the next quarter with improved operational visibility and a clear strategy to restore growth and profitability.
Informational and educational content only. Not investment advice.